Search
  • Carmentix

News coverage of PPeTaL study in Melbourne


The collaboration between Carmentix and the University of Melbourne, known as the Predicting Preterm Labour (PPeTaL) study, has been covered by various news outlet in Australia. The study aims to recruit over 3000 expecting women over 3 years as part of a multi-center prospective study.

Carmentix and the University of Melbourne have worked together to identify various biomarkers that has been shown to be associated with women at labor in a retrospective study. The PPeTaL prospective study will allow us to further validate and fine tune these biomarkers. This will allow us to finalize a set of biomarkers which can accurately predict asymptomatic women who are at a high risk of preterm birth.


The PPeTaL study is led by chief executive officer Nir Arbel and his team of scientist at Carmentix, together with Prof Shaun Brennecke, Dr Harry Georgiou and Dr Megan Di Quinzio from the University of Melbourne.


For more on the news coverage:


http://newsroom.melbourne.edu/news/pre-term-babies-could-benefit-study-melbourne-mums


http://www.portnews.com.au/story/5224859/predicting-premature-labour-focus-of-study/


14 views

Redefining the future of women's heath

Contact Us

LaunchPad @ one-north

71 Ayer Rajah Crescent

#03-23/34

Singapore 139951

An Esco Ventures X company

© 2019 by Carmentix Pte Ltd. All Rights Reserved.